{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:40Z","timestamp":1782722740816,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xkme.2026.101407","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:37:09Z","timestamp":1778765829000},"page":"101407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["I-131 Use in Patients With Kidney Failure Receiving Dialsyis: Therapeutic Challenges and Evidence From Literature"],"prefix":"10.1016","volume":"8","author":[{"given":"Abhirami","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Kafrouni Gerges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2026.101407_bib1","article-title":"Cross-section of thyroidology and nephrology: literature review and key points for clinicians","volume":"37","author":"Chehade","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"issue":"7","key":"10.1016\/j.xkme.2026.101407_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00259-008-0761-x","article-title":"EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: Blood and bone marrow dosimetry in differentiated thyroid cancer therapy","volume":"35","author":"Lassmann","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.xkme.2026.101407_bib3","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2574::AID-CNCR22>3.0.CO;2-O","article-title":"Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma","volume":"77","author":"Bal","year":"1996","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.xkme.2026.101407_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/thy.1996.6.301","article-title":"Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis","volume":"6","author":"Daumerie","year":"1996","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.xkme.2026.101407_bib5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1089\/thy.2005.15.1321","article-title":"Radioiodine therapy for thyroid cancer and hyperthyroidism in patients with end-stage renal disease on hemodialysis","volume":"15","author":"Holst","year":"2005","journal-title":"Thyroid"},{"issue":"639","key":"10.1016\/j.xkme.2026.101407_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1259\/0007-1285-54-639-259","article-title":"Iodine 131 ablation therapy for a patient on maintenance haemodialysis","volume":"54","author":"Howard","year":"1981","journal-title":"Br J Radiol"},{"issue":"8","key":"10.1016\/j.xkme.2026.101407_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2967\/jnumed.119.232017","article-title":"Management of patients with renal failure undergoing dialysis during 131I therapy for thyroid cancer","volume":"61","author":"Vermandel","year":"2020","journal-title":"J Nucl Med"},{"issue":"11","key":"10.1016\/j.xkme.2026.101407_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/105072501753271716","article-title":"Iodine-131 treatment of thyroid papillary carcinoma in patients undergoing dialysis for chronic renal failure: a dosimetric method","volume":"11","author":"Jim\u00e9nez","year":"2001","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.xkme.2026.101407_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ki.2008.95","article-title":"Hemodialysis of chronic kidney failure patients requiring ablative radioiodine therapy","volume":"73","author":"Murcutt","year":"2008","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.xkme.2026.101407_bib10","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1002\/1097-0142(19901215)66:12<2509::AID-CNCR2820661211>3.0.CO;2-M","article-title":"131I treatment of thyroid papillary carcinoma in a patient with renal failure","volume":"66","author":"Morrish","year":"1990","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.xkme.2026.101407_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jjco\/hyf049","article-title":"Disposition of radioiodine (131)I therapy for thyroid carcinoma in a patient with severely impaired renal function on chronic dialysis: a case report","volume":"32","author":"Magn\u00e9","year":"2002","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101407_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.HP.0000214660.13440.64","article-title":"The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients\u2014a pharmacokinetic model","volume":"91","author":"Pahlka","year":"2006","journal-title":"Health Phys"},{"issue":"4","key":"10.1016\/j.xkme.2026.101407_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1055\/s-0042-1750405","article-title":"Delivery of radioiodine ablation in a patient with end-stage renal disease","volume":"21","author":"Bussey","year":"2022","journal-title":"World J Nucl Med"},{"issue":"3","key":"10.1016\/j.xkme.2026.101407_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000168621","article-title":"Iodine-131 treatment of hyperthyroidism in a patient on dialysis for chronic renal failure","volume":"13","author":"Nibhanupudy","year":"1993","journal-title":"Am J Nephrol"},{"issue":"2-4","key":"10.1016\/j.xkme.2026.101407_bib15","first-page":"1","article-title":"Ann ICRP","volume":"37","year":"2007","journal-title":"ICRP Publication 103"},{"issue":"6","key":"10.1016\/j.xkme.2026.101407_bib16","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.4158\/EP10170.RA","article-title":"Early and late toxicity of radioiodine therapy: detection and management","volume":"16","author":"Hyer","year":"2010","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.xkme.2026.101407_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00003072-199409000-00006","article-title":"Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis","volume":"19","author":"Mello","year":"1994","journal-title":"Clin Nucl Med"},{"issue":"3","key":"10.1016\/j.xkme.2026.101407_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MNM.0000000000000439","article-title":"Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure","volume":"37","author":"Yeyin","year":"2016","journal-title":"Nucl Med Commun"},{"issue":"9","key":"10.1016\/j.xkme.2026.101407_bib19","first-page":"3058","article-title":"Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy","volume":"85","author":"Kaptein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.xkme.2026.101407_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00003072-200104000-00004","article-title":"Iodine-131 ablation therapy for a patient receiving peritoneal dialysis","volume":"26","author":"Toubert","year":"2001","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101407_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1525-139X.2004.17114.x","article-title":"Radioactive 131I use in end-stage renal disease: nightmare or nuisance?","volume":"17","author":"Sinsakul","year":"2004","journal-title":"Semin Dial"},{"issue":"2","key":"10.1016\/j.xkme.2026.101407_bib22","first-page":"110","article-title":"Clearance of 131I by hemodialysis","volume":"38","author":"Culpepper","year":"1992","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.xkme.2026.101407_bib23","first-page":"17","article-title":"Dosing of radioactive iodine in end-stage renal disease patient with thyroid cancer","volume":"2017","author":"Bhat","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"10.1016\/j.xkme.2026.101407_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2967\/jnmt.121.261979","article-title":"Radioiodine therapy in patient with differentiated thyroid cancer and end-stage renal disease on maintenance hemodialysis: case report with review of literature","volume":"50","author":"Kumar","year":"2022","journal-title":"J Nucl Med Technol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952600169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952600169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:07:50Z","timestamp":1782720470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952600169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S259005952600169X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101407","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"I-131 Use in Patients With Kidney Failure Receiving Dialsyis: Therapeutic Challenges and Evidence From Literature","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101407"}}